Unimicron Technology (3037) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
13 Jun, 2025Executive summary
Q3 2024 consolidated sales were NT$31,712M, up 13.8% sequentially and 19% year-over-year; nine-month revenue was NT$85,992M, up 10% year-over-year.
Q3 2024 net income was NT$997M–NT$1,090M, down 37% sequentially and 62% year-over-year; nine-month net income was NT$5,026M, down 45% year-over-year.
Gross margin improved to 15.6%–16% in Q3 2024 from Q2, but declined from 20%–20.2% a year ago.
The company completed the Subtron Technology integration, with a further merger planned for January 2025.
Financial highlights
Q3 2024 operating income was NT$1,962M, up 119% sequentially; nine-month operating profit was NT$7,529M, down from NT$12,917M year-over-year.
EBITDA for Q3 2024 was NT$6,053M (19% of sales), down from NT$6,577M (24%) in Q2 2024.
Basic EPS for Q3 2024 was NT$0.66; nine-month EPS was NT$3.30, down from NT$5.97 year-over-year.
Cash at end of Q3 2024 was NT$40,036M, down from NT$50,986M at end of Q2 and NT$51,233M a year earlier.
Total assets increased to NT$228,209M from NT$215,549M at September 30, 2023.
Outlook and guidance
Forward-looking statements highlight risks and uncertainties that may cause actual results to differ materially from projections.
Board approved a THB 3,500M capital increase for the Thailand subsidiary to support expansion.
Ongoing investments in capacity and technology to support long-term growth.
Latest events from Unimicron Technology
- Q4 2025 delivered higher sales, margins, and net income, led by substrate and automotive growth.3037
Q4 202525 Feb 2026 - Net sales up 12% to NT$96.55B, net income down 38%, with new bonds and HK listing planned.3037
Q3 202512 Dec 2025 - Revenue up 15% but profit and margins fell sharply amid major merger and FX risks.3037
Q2 20258 Sep 2025 - Q1 2025 revenue rose 14% year-over-year, but net income and margins declined.3037
Q1 202519 Jun 2025 - Revenue rose but profit and margins fell due to higher costs and margin pressure.3037
Q2 202413 Jun 2025 - Sales up 11%, net income down 55–58%, dividend proposed, inventory risk persists.3037
Q4 20245 Jun 2025